StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.58−0.13 (-4.80%)

Close on Nov 12, 2026Market cap $77.56KP/E –Yield –

Neuphoria Therapeutics statistics

58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$77.56K
$280.48M
Enterprise Value
-$19.79M
$148.62M
PB Ratio
0.00
2.05
P/TBV Ratio
0.00
2.29

Share statisticsIndustry

Shares Change (YoY)
170.9%
10.9%
Shares Change (QoQ)
0.63%
0.51%
Shares Held by Institutions
36.8%
56.4%

Short sellingIndustry

Short Interest
12,377
–
Short Interest Change
92.5%
-0.76%
Days to Cover
1.00
5.13

Stock price statisticsIndustry

52-Week High
$5.53
–
52-Week Low
$2.54
–
20-Day Moving Average
$3.10
–
50-Day Moving Average
$3.39
–
200-Day Moving Average
$4.11
–
Average True Range (14)
$0.14
–
Price Change (1 Week)
-6.86%
1.51%
Price Change (1 Month)
-20.4%
-2.35%
Price Change (3 Months)
-33.3%
-21.1%
Price Change (6 Months)
-49.3%
-22.6%
Price Change (YTD)
-33.5%
-22.6%
Price Change (1 Year)
-47.2%
-20.7%
Price Change (3 Years)
-89.1%
-27.4%
Average Volume (10 Days)
37,514
–
Average Volume (20 Days)
36,892
–
Average Volume (90 Days)
124,830
–
Relative Volume
0.16
0.79
Relative Strength Index (14)
15.6
44.7
Volatility (1 Year)
51.1%
80.4%
Beta (5 Years)
0.85
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-61.7%
-51.2%
Return on Assets (ROA)
-47.0%
-40.6%
Return on Invested Capital (ROIC)
-272.9%
-32.9%
Return on Capital Employed (ROCE)
-58.9%
-38.0%

Financial positionIndustry

Current Ratio
27.85
3.30
Quick Ratio
27.33
2.42

EfficiencyIndustry

Profits Per Employee
-$1.92M
-$683.67K
Employee Count
7
75
WACC
9.25%
10.1%

Income statement (TTM)Industry

Operating Income
-$16.45M
-$20.99M
Pretax Income
-$13.59M
-$13.23M
Net Income
-$13.45M
-$21.61M
EBITDA
-$15.79M
-$16.85M

Balance sheetIndustry

Net Cash (Debt)
$19.87M
$17.46M
Net Cash Per Share
$3.67
$0.72
Equity (Book Value)
$24.60M
$53.27M
Book Value Per Share
$4.55
$1.50
Tangible Book Value
$16.96M
$26.82M
Working Capital
$20.31M
$79.47M

Cash flow (TTM)Industry

Operating Cash Flow
-$12.35M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-17343.4%
-20.8%
Buyback Yield
-23098.7%
-0.73%
Shareholder Yield
-23098.7%
0.00%

Taxes and interestIndustry

Income Tax
-$139.17K
$74.00K

Scores and fair valueIndustry

Altman Z-Score
-10.38
0.30
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodNEUPS&P 500DifferenceNEUP per yearS&P 500 per year
1 month-22.3%-2.7%−19.6 pts
3 months-32.3%-1.7%−30.5 pts
Year to date-33.5%+11.9%−45.4 pts
1 year-47.3%+12.0%−59.3 pts
3 years-87.6%+78.2%−165.8 pts-50.2%+21.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M NEUP shares were sold short on Oct 30, 2026, up 92.5% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 33.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202612,377+92.5%37,9981.0
Oct 15, 20266,429-67.9%16,4471.0
Sep 30, 202620,022-19.0%12,4241.6
Sep 15, 202624,713-61.8%20,2041.2
Aug 31, 202664,641+53.8%67,6951.0
Aug 14, 202642,034-35.9%28,8321.5
Jul 31, 202665,538+327.4%638,7201.0
Jul 15, 202615,334-3.1%109,7471.0
Jun 30, 202615,831-31.3%78,3091.0
Jun 15, 202623,029-37.5%76,1961.0
May 29, 202636,835+88.0%59,8271.0
May 15, 202619,598-57.4%28,0891.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?